Your interpretation of $2-$3 being about right is probably because that's the range it's trading in.
Any analysis of the potential value and likelihood based on trial data, independent medical research, appropriate discounting rates, and market sizing says this should be $1B -$3B market cap now IMO.
Time to get some progress in and out of the clinic, and time to get accurate, compelling messages out there.
RAC - Charts & Price Action, page-14350
-
- There are more pages in this discussion • 7,161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
-0.010(0.55%) |
Mkt cap ! $307.3M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.84 | $1.78 | $271.2K | 150.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 349 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |